Genmab Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	15,192	19,785	13,813	21,038	27,955	25,998
Market Cap Growth	7.64%	43.23%	-34.34%	-24.74%	7.52%	-2.45%
Enterprise Value	19,042	25,059	11,003	16,986	24,827	23,106
Last Close Price	24.58	30.80	20.87	31.84	42.38	39.56
PE Ratio	18.50	20.04	11.91	33.24	35.61	58.18
PS Ratio	3.89	5.32	4.43	8.80	13.39	20.20
PB Ratio	2.67	-	2.69	4.50	7.12	7.66
P/TBV Ratio	-	-	4.42	4.50	7.16	7.79
P/FCF Ratio	17.42	17.22	12.57	20.67	54.02	86.03
P/OCF Ratio	16.84	16.68	12.27	19.64	49.65	76.30
EV/Sales Ratio	4.88	6.74	3.53	7.11	11.89	17.95
EV/EBITDA Ratio	14.32	22.06	10.66	20.84	26.02	47.20
EV/EBIT Ratio	14.80	23.53	11.32	22.00	27.52	51.17
EV/FCF Ratio	21.84	21.81	10.01	16.69	47.98	76.46
Debt / Equity Ratio	-	-	0.03	0.02	0.02	0.02
Debt / EBITDA Ratio	4.93	4.64	0.14	0.14	0.09	0.13
Debt / FCF Ratio	-	4.59	0.13	0.11	0.17	0.22
Net Debt / Equity Ratio	-	-	-0.55	-0.87	-0.80	-0.85
Net Debt / EBITDA Ratio	4.93	4.64	-2.72	-4.97	-3.28	-5.91
Net Debt / FCF Ratio	-	4.59	-2.56	-3.98	-6.04	-9.57
Asset Turnover	0.63	1.16	0.54	0.50	0.52	0.36
Quick Ratio	-	0	5.24	13.34	15.51	14.52
Current Ratio	-	0	5.24	13.34	15.48	14.50
Return on Equity (ROE)	-	46.88%	27.01%	18.98%	21.44%	13.84%
Return on Assets (ROA)	13.91%	33.21%	16.70%	16.15%	17.48%	9.42%
Return on Invested Capital (ROIC)	13.32%	65.76%	52.85%	97.36%	97.41%	56.01%
Return on Capital Employed (ROCE)	17.87%	39.47%	18.47%	17.29%	23.74%	13.30%
Earnings Yield	5.40%	4.99%	8.40%	3.01%	2.81%	1.72%
FCF Yield	5.74%	5.81%	7.96%	4.84%	1.85%	1.16%
Buyback Yield / Dilution	2.55%	3.04%	1.88%	0.17%	0.05%	-0.24%
Total Shareholder Return	2.55%	3.04%	1.88%	0.17%	0.05%	-0.24%

SEC Filings: 10-K · 10-Q